Cargando…
Corrigendum to “Dexmedetomidine Ameliorates Hippocampus Injury and Cognitive Dysfunction Induced by Hepatic Ischemia/Reperfusion by Activating SIRT3-Mediated Mitophagy and Inhibiting Activation of the NLRP3 Inflammasome in Young Rats”
Autores principales: | Yu, Wenli, Lyu, Jingshu, Jia, Lili, Sheng, Mingwei, Yu, Hongli, Du, Hongyin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360743/ https://www.ncbi.nlm.nih.gov/pubmed/34398166 http://dx.doi.org/10.1155/2021/9797165 |
Ejemplares similares
-
Dexmedetomidine Ameliorates Hippocampus Injury and Cognitive Dysfunction Induced by Hepatic Ischemia/Reperfusion by Activating SIRT3-Mediated Mitophagy and Inhibiting Activation of the NLRP3 Inflammasome in Young Rats
por: Yu, Wenli, et al.
Publicado: (2020) -
Mitophagy: a balance regulator of NLRP3 inflammasome activation
por: Kim, Min-Ji, et al.
Publicado: (2016) -
Corrigendum to “ALDH2 Overexpression Alleviates High Glucose-Induced Cardiotoxicity by Inhibiting NLRP3 Inflammasome Activation”
por: Cao, Ruiping, et al.
Publicado: (2021) -
Administration of Dexmedetomidine inhibited NLRP3 inflammasome and microglial cell activities in hippocampus of traumatic brain injury rats
por: Zheng, Bin, et al.
Publicado: (2018) -
Corrigendum: Amyloid‐β activates NLRP3 inflammasomes by affecting microglial immunometabolism through the Syk‐AMPK pathway
Publicado: (2022)